Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000316374 | SCV000335621 | likely benign | not specified | 2015-09-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000643246 | SCV000764933 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-12-06 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000768916 | SCV000900289 | uncertain significance | Cardiomyopathy | 2016-10-27 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293049 | SCV001434029 | likely benign | Hypertrophic cardiomyopathy | criteria provided, single submitter | research | ||
Gene |
RCV001707610 | SCV001936033 | benign | not provided | 2020-03-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000316374 | SCV002511953 | likely benign | not specified | 2022-04-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002347994 | SCV002646028 | likely benign | Cardiovascular phenotype | 2018-09-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004535298 | SCV004726630 | likely benign | TTN-related disorder | 2022-01-31 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |